Blood testing has been their cash cow.
There are lots of other places to cut costs, including direct-to-consumer advertising. But even with a radical restructuring, Pfizer will need multiple new blockbusters to make up for shrinking sales of drugs losing patent protection -- and doesn't have them.
Copyright © 2024 Electric Goat Media. All Rights Reserved.